Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: WM Partners Acquires Allergy Research Group

    ARG, founded in 1979 and based in South Salt Lake, Utah, sells hypoallergenic supplements focused on addressing condition-specific...
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Xlumena Closes $25 Million In Series C Financing

    Xlumena, Inc., has announced it has closed $25 million in Series C financing.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    HHS Withdraws Breach Notification Final Rule

    On August 28, 2010, the U.S. Department of Health and Human Services (HHS) announced on its website that it has withdrawn the final breach notification rule from the Office of Management and Budget (OMB) to "allow for further consideration, given the Department's experience to date in administering the regulations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Hospital's Cloud-Based Document-Sharing Practices Lead To $218,400 HIPAA Settlement

    On July 10, 2015, the U.S. Department of Health and Human Services Office for Civil Rights (OCR) announced a substantial settlement with St. Elizabeth's Medical Center (SEMC).
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    House Republications Expected To Propose SGR Repeal Funded By Delaying Individual Mandate

    Republicans in the House are expected to vote this week on legislation that would permanently repeal the SGR Medicare physician payment formula.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Indiana Passes Pain Management Clinic Legislation: Four Key Points

    Indiana Governor Mike Pence recently signed Indiana Senate Bill 246 into law , which requires registration and possible inspection of practices, including pain management clinics, that prescribe controlled substances. Indiana’s law demonstrates the increasing trend of states passing legislation to regulate pain management clinics.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Insight From MedPac For Private Equity Investors

    McGuireWoods has a sister consulting group in D.C. and several state capitals who are knowledgeable about impending changes for our healthcare clients.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Investors' Interest In Dermatology Is More Than Skin-Deep

    With many successful private equity investments occurring since 2012, regulatory challenges may pose very little resistance to this fast-expanding subsector.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Long-Term Care Hospitals And Satellite Development Projects To Be Impacted By Passage Of The "Doc Fix" Bill

    The House of Representatives approved a bill by voice vote to extend Medicare physician pay rates through March 31, 2015.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Lux Capital Raises $350 Million Fund To Back Startup Healthcare And Technology Companies

    Lux Capital has announced it has closed a new $350 million fund that will invest in early-stage science and technology ventures.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    March 31, 2014 — Deadline For Eligible Professional Meaningful Use Reporting

    CMS extended the deadline for Medicare eligible professionals to submit their 2013 meaningful use attestations from Feb. 28, 2014, to March 31, 2014.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Office Of Inspector General To Focus Enforcement On Five Areas Of FDA Regulation

    The Office of the Inspector General (OIG) recently released its Work Plan for Fiscal Year 2013 (Work Plan) in which the OIG summarizes new and ongoing reviews and activities that it plans to pursue with respect to the Department of Health and Human Services programs and operations during 2013 and beyond.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    OIG To Provide Updated Guidance On Exclusion Authority; 3 Things All Providers Can Expect

    The Department of Health and Human Services Office of Inspector General plans to release updated guidance on its exclusion authority within the next few months.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    PE-Backed Lab Company Millennium Health To Pay $256 Million Settlement With Government

    We've discussed in the past certain risks of which investors should be aware with laboratory investments.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Physician Compensation By Hospitals Drawing Increased Legal Attention

    Healthcare Services Investing
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Proposed Rule Would Allow Medicare Advantage Plans To Limit Patient Choice Of Medical Devices

    On October 11, 2011, the Centers for Medicare and Medicaid Services (CMS) proposed changes to Medicare Part C regulations that would enable Medicare Advantage (MA) plans to limit access to Medicare-covered items, including limiting coverage to specific items and brands of durable medical equipment (DME) supplies.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Silversmith Capital Closes First PE Fund Focused On Healthcare, Technology

    Silversmith Capital Partners has announced it has closed on its first private equity fund — Silversmith Capital Partners I — at $460 million of commitments.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Study: Disruptive Changes Could Cost Medical Device Industry $34 Billion By 2020

    A new study identifies five disruptive forces that could cost the medical device industry $34 billion over the next five years.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Surefire Medical Closes $18.2 In Series B Funding From Partisan Management Group

    Surefire Medical, Inc., has announced it has completed a $18.2 million Series B funding.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Texas Passes Bill Establishing "Wall Of Shame" For Data Breaches

    On May 31, 2021, the Texas Legislature approved House Bill 3746, which seeks to amend the Texas Business and Commerce Code § 521.053 relating to certain notifications required following a breach of ...
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP

Showing 541–560 of 3625 results

PreviousNext
Legal Intelligence Newsletters